• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Addressing Gaps in Racial/Ethnic Representation in Familial Hypercholesterolemia Registries: Implications and Recommendations for Equitable Access to Research and Care.

作者信息

Mszar Reed, Santos Raul D, Nasir Khurram

机构信息

Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT (R.M.).

Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital Brazil (R.D.S.).

出版信息

Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e007306. doi: 10.1161/CIRCOUTCOMES.120.007306. Epub 2021 Jan 29.

DOI:10.1161/CIRCOUTCOMES.120.007306
PMID:33508946
Abstract
摘要

相似文献

1
Addressing Gaps in Racial/Ethnic Representation in Familial Hypercholesterolemia Registries: Implications and Recommendations for Equitable Access to Research and Care.解决家族性高胆固醇血症登记中种族/族裔代表性的差距：公平获取研究和医疗服务的影响及建议
Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e007306. doi: 10.1161/CIRCOUTCOMES.120.007306. Epub 2021 Jan 29.
2
Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.家族性高胆固醇血症的临床决定因素及治疗差距：来自多民族地区卫生服务机构的数据
Eur J Prev Cardiol. 2017 May;24(8):867-875. doi: 10.1177/2047487317693132. Epub 2017 Feb 10.
3
Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care.患有家族性高胆固醇血症的女性：围绕其护理的挑战和考虑因素。
Curr Atheroscler Rep. 2020 Aug 20;22(10):60. doi: 10.1007/s11883-020-00881-5.
4
The role of registries and genetic databases in familial hypercholesterolemia.登记处和基因数据库在家族性高胆固醇血症中的作用。
Curr Opin Lipidol. 2017 Apr;28(2):152-160. doi: 10.1097/MOL.0000000000000398.
5
Supports and gaps in federal policy for addressing racial and ethnic disparities among long-term care facility residents.联邦政策在解决长期护理机构居民种族和民族差异方面的支持与差距。
J Gerontol Soc Work. 2020 May-Jun;63(4):354-370. doi: 10.1080/01634372.2020.1758270. Epub 2020 Apr 27.
6
Familial hypercholesterolemia: experience from the French-Canadian population.家族性高胆固醇血症：来自法裔加拿大人群的经验。
Curr Opin Lipidol. 2018 Apr;29(2):59-64. doi: 10.1097/MOL.0000000000000487.
7
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.家族性高胆固醇血症基金会 CAscade 筛查以提高对家族性高胆固醇血症的认识和检测的注册研究的基本原理和设计。
Am Heart J. 2014 Mar;167(3):342-349.e17. doi: 10.1016/j.ahj.2013.12.008. Epub 2013 Dec 21.
8
Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.家族性高胆固醇血症：美国国家脂质协会家族性高胆固醇血症专家小组的患病率、遗传学、诊断及筛查建议
J Clin Lipidol. 2011 Jun;5(3 Suppl):S9-17. doi: 10.1016/j.jacl.2011.03.452. Epub 2011 Apr 3.
9
Screening and management of familial hypercholesterolemia.家族性高胆固醇血症的筛查和管理。
Curr Opin Cardiol. 2019 Sep;34(5):526-530. doi: 10.1097/HCO.0000000000000660.
10
Examining barriers to cascade screening for familial hypercholesterolemia in the United States.审视美国家族性高胆固醇血症级联筛查的障碍。
J Clin Lipidol. 2016 Mar-Apr;10(2):225-7. doi: 10.1016/j.jacl.2015.12.019. Epub 2015 Dec 23.

引用本文的文献

1
Sex and racial differences in prevalence and clinical characteristics of people living with LDLR and PCSK9 familial hypercholesterolemia genetic variants: Data from the All of Us Research program.携带低密度脂蛋白受体（LDLR）和前蛋白转化酶枯草溶菌素9（PCSK9）家族性高胆固醇血症基因变异人群的患病率及临床特征的性别和种族差异：来自“我们所有人”研究项目的数据
Am J Prev Cardiol. 2025 Jun 1;22:101024. doi: 10.1016/j.ajpc.2025.101024. eCollection 2025 Jun.
2
Hypercholesteremia in Indigenous Population: The Imperative for Culturally Sensitive Interventions and Collaborative Research.原住民中的高胆固醇血症：开展具有文化敏感性的干预措施与合作研究的必要性
JACC Adv. 2023 May 26;2(3):100352. doi: 10.1016/j.jacadv.2023.100352. eCollection 2023 May.
3
Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial.
家庭级联筛查以公平识别家族性高胆固醇血症：一项混合有效性-实施类型 III 随机对照试验的研究方案。
Implement Sci. 2024 Apr 9;19(1):30. doi: 10.1186/s13012-024-01355-x.
4
Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID-19 pandemic.COVID-19 大流行期间家族性高胆固醇血症患者心血管管理和预防服务的获取障碍和不足。
Clin Cardiol. 2023 Aug;46(8):831-844. doi: 10.1002/clc.24059. Epub 2023 Jun 1.
5
Gaps in the Care of Subjects with Familial Hypercholesterolemia: Insights from the Thai Familial Hypercholesterolemia Registry.家族性高胆固醇血症患者的护理缺口：来自泰国家族性高胆固醇血症登记处的见解。
J Atheroscler Thromb. 2023 Dec 1;30(12):1803-1816. doi: 10.5551/jat.64081. Epub 2023 May 18.